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Abstract
 
The contribution of accessory toxins to the acute inflammatory response to 
 
Vibrio cholerae
 
 was
assessed in a murine pulmonary model. Intranasal administration of an El Tor O1 
 
V. cholerae
 
strain deleted of cholera toxin genes (
 
ctxAB
 
) caused diffuse pneumonia characterized by infiltra-
tion of PMNs, tissue damage, and hemorrhage. By contrast, the 
 
ctxAB
 
 mutant with an addi-
tional deletion in the actin-cross-linking repeats-in-toxin
 
 (
 
RTX) toxin gene (
 
rtxA
 
) caused a less
severe pathology and decreased serum levels of proinflammatory molecules interleukin (IL)-6
and murine macrophage inflammatory protein (MIP)-2. These data suggest that the RTX toxin
contributes to the severity of acute inflammatory responses. Deletions within the genes for ei-
ther hemagglutinin/protease (
 
hapA
 
) or hemolysin (
 
hlyA
 
) did not significantly affect virulence in
this model. Compound deletion of 
 
ctxAB
 
, 
 
hlyA
 
, 
 
hapA
 
, and 
 
rtxA
 
 created strain KFV101, which
colonized the lung but induced pulmonary disease with limited inflammation and significantly
reduced serum titers of IL-6 and MIP-2. 100% of mice inoculated with KFV101 survive, com-
pared with 20% of mice inoculated with the 
 
ctxAB
 
 mutant. Thus, the reduced virulence of
KFV101 makes it a prototype for multi-toxin deleted vaccine strains that could be used for pro-
tection against 
 
V. cholerae
 
 without the adverse effects of the accessory cholera toxins.
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Introduction
 
Vibrio cholerae
 
 is the classic example of a noninvasive en-
teric pathogen that induces a highly secretory diarrhea in
the absence of an inflammatory response (1, 2). Of diag-
nostic and clinical significance, there is a paucity of ana-
tomic pathology in the intestines of patients with cholera
(3). Indeed, death of cholera victims is primarily caused by
secondary dehydration due to massive intestinal fluid loss,
not intestinal damage or septicemia. The virulence factor
predominantly responsible for this watery diarrhea is chol-
 
era toxin (CT),
 
*
 
 a powerful enterotoxin encoded by the
 
ctxA
 
 and 
 
ctxB
 
 genes carried on the transmissible prophage
CTX
 
 
 
 (4, 5).
“Nontoxigenic” variants of 
 
V. cholerae
 
 that do not carry
the integrated CTX
 
 
 
 prophage also cause disease, includ-
ing sporadic outbreaks of watery diarrhea and isolated in-
cidences of extraintestinal infections, septicemia, and in-
flammatory enterocolitis (2, 6–8). In clinical trials of live
attenuated vaccine strains, it was shown that lactoferrin, a
physiological marker for the presence of neutrophils, was
present at higher titers in the stool of human volunteers
given the CT-deficient vaccine strain compared with vol-
 
Address correspondence to Karla J. Fullner, Ph.D., Department of Micro-
biology-Immunology, Northwestern University, Feinberg School of Med-
icine, 303 E. Chicago Ave. Morton 6-626, Chicago, IL 60611. Phone:
312-503-2162; Fax: 312-503-1339; E-mail: k-fullner@northwestern.edu
 
*
 
Abbreviations used in this paper:
 
 CT, cholera toxin; HAP, hemaggluti-
nin/protease; H/E, hematoxylin and eosin; MIP, murine macrophage in-
flammatory protein; RTX, repeats-in-toxin. 
1456
 
Proinflammatory Response to 
 
Vibrio cholerae
 
 Accessory Toxins
 
unteers given the CT-producing control strains (9). These
results suggest that 
 
V. cholerae
 
 strains that do not produce CT
induce a more inflammatory diarrhea, rather than the non-
inflammatory disease associated with CT-producing strains.
The development of inflammatory diarrhea in the ab-
sence of CT may be due to loss of immunomodulatory
signaling by CT (10). CT has been shown in vitro to
block production of proinflammatory cytokines TNF
 
 
 
,
IL-1
 
 
 
, and IL-12 by LPS-stimulated monocytes and den-
dritic cells (11, 12). Thus, in addition to stimulating fluid
secretion through activation of adenylate cyclase activity
(4), CT suppresses induction of inflammation during 
 
V.
cholerae
 
 infection.
In vitro studies have identified cytotoxic factors other
than CT secreted by 
 
V. cholerae
 
 that may cause tissue dam-
age that, in turn, could contribute to induction of proin-
flammatory responses. These “accessory toxins” of 
 
V. chol-
erae
 
 include the repeats-in-toxin (RTX) toxin, which
causes cell rounding and increased permeability through
paracellular tight junctions due to covalent cross-linking of
actin monomers leading to depolymerization of actin stress
fibers (13–15); hemagglutinin/protease (HAP), which de-
grades occludin in paracellular tight junctions leading to
separation of paracellular tight junctions and desquamation
of tissue (16–20); and, hemolysin, which causes necrosis of
intestinal epithelial cells, growth of mildly acidic vacuoles,
and hemolysis depending upon the cell type and toxin con-
centration (21–27). The contribution of these cytotoxins to
the stimulation of the proinflammatory response in vivo has
not been previously examined, in part due to insufficient
animal models for such studies.
Although studies using infant mice and adult rabbits are
well documented, 
 
V. cholerae
 
 is rapidly cleared from the
intestine of adult mice (28, 29). Hence, in vivo studies of
the acute immunobiological responses to 
 
V. cholerae
 
 infec-
tion have not been feasible. Studies of 
 
Shigella flexneri
 
, the
causative agent of bacillary dysentery, have been similarly
hampered by the lack of a mouse intestinal infection
model. Surprisingly, the mouse lung was shown to be a
suitable substitute for evaluation of local and systemic im-
mune responses to 
 
S. flexneri
 
 challenge (30–32). This
model is based on the premise that the bronchial tree is
composed of a mucosal lining with relevant characteristics
similar to the intestine including simple cubodial to co-
lumnar epithelial cells, lymphoid aggregates (bronchiole
associated lymphoid tissue [BALT]) similar to Peyer’s
patches, and the presence of several varieties of antigen-
presenting cells (32).
Using this murine pulmonary model for dysentery, 
 
V.
cholerae
 
 was tested for its ability to cause disease when inoc-
ulated intranasally. A CT-negative strain of 
 
V. cholerae
 
 was
found to be highly infectious to the pulmonary system
leading to a diffuse pneumonia. The production of proin-
flammatory signal molecules IL-6 and murine macrophage
inflammatory protein 2 (MIP-2) and the severity of disease
correlated with the specific repertoire of extracellular tox-
ins expressed by the infecting 
 
V. cholerae
 
 strain.
 
Materials and Methods
 
Construction of Plasmids pCW
 
 
 
rtxA and pCW
 
 
 
hlyA.
 
Gene
sequences upstream of 
 
rtxA
 
 and 87 bp of 
 
rtxA
 
 was amplified from
 
V. cholerae
 
 El Tor N16961 by PCR using primers 3399 (5
 
 
 
-
CGATTACCGCTGATGATACTTAA) and 4319B (5
 
 
 
-AGT-
GACTCGAATGGCTACAATGTTGTTGTTTCC). The am-
plified product was cloned into pCR2.1 using the TA cloning kit
(Invitrogen). The insert was then excised by EcoRI digestion and
moved into the EcoRI site of pWL80, which has the 3.8-kb
EcoRI-HindIII fragment of 
 
rtxA
 
 cloned in pBluescriptII (14).
The resulting gene fusion removed codons for amino acid (aa) 30
to aa 2634 from the 
 
rtxA
 
 gene with sufficient flanking sequences
for recombination. The fused gene was moved to the polylinker
of sucrose counter-selectable plasmid pWM91 (33) to create
pCW
 
 
 
rtxA
 
.
A 3.3-kb DNA segment including the entire 
 
hlyA
 
 gene and
flanking DNA was amplified from N16961 by PCR using prim-
ers hlyA6215 (5
 
 
 
-TTTCTTGCAGTAGCATCATATCGATA)
and hlyA2980 (5
 
 
 
-AATCTGTGATCCGCTGTGAATTTTCAA).
The amplified product was cloned into pCR2.1 using the TA
cloning kit (Invitrogen). The resulting plasmid was digested with
NruI and SnaBI and was relegated to delete codons for aa 8 to
595 of the 
 
hlyA
 
 gene. The resulting 
 
 
 
hlyA
 
 fragment was moved
to the polylinker of sucrose counter-selectable plasmid pWM91
(33) to create pCW
 
 
 
hlyA
 
.
 
Bacterial Strains.
 
All strains are derived from the streptomy-
cin-resistant isolate of the 
 
V. cholerae
 
 O1 El Tor Inaba strain
P27459, originally isolated in Bangladesh in 1979 (34). 
 
V. cholerae
 
P4 (a.k.a. SM44) has an engineered mutation replacing the 
 
ctxA
 
and 
 
ctxB
 
 genes on the integrated CTX
 
 
 
 prophage in P27459
with a gene for kanamycin resistance (35). P4 was further geneti-
cally engineered to generate unmarked internal deletions in the
genes for the RTX toxin (
 
rtxA
 
), HAP (
 
hapA
 
), and hemolysin
(
 
hlyA
 
). Protocols for 
 
sacB
 
-counterselection in 
 
V. cholerae
 
 has been
described previously (36). Briefly, plasmids pCW
 
 
 
rtxA
 
 (this
study), pCW
 
 
 
hlyA
 
 (this study), and pCVD
 
 
 
hap
 
Sal (36) were
transferred to P4 by conjugation from SM10
 
 
 
pir and cointegrants
were selected by growth on kanamycin and ampicillin. Loss of
the 
 
sacB
 
 gene due to resolution of the cointegrant in the absence
of antibiotic selection was selected on 6% sucrose plates. Rever-
sion to either wild-type or deleted gene arrangements were dis-
tinguished by PCR analysis and by assaying for loss of cell round-
ing, proteolytic, or hemolytic activities.
 
Inoculation of Mouse Lungs.
 
Prior to inoculation into mice,
bacterial cultures were grown in 5 ml Luria broth with 100 
 
 
 
g/
ml streptomycin and 50 
 
 
 
g/ml kanamycin at 30
 
 
 
C overnight
with shaking. The bacteria were pelleted, washed twice with
PBS, and adjusted to the desired CFU/ml based on empirical
observation that an A
 
600
 
 of 0.5 contains 10
 
9
 
 CFU 
 
V. cholerae
 
 per
ml. The actual CFU/ml was determined by plating dilutions of
the inocula.
All animal procedures were performed as directed by ACUC
approved protocols at Harvard Medical School or Northwestern
University Medical School. 5–7-wk-old female specific pathogen
free BALB/c mice (Taconic or Harlan Laboratories) were in-
jected intraperitoneal with 6 mg/kg ketamine and 1.25 mg/kg
xylazine combined in 50 
 
 
 
l PBS. When the mice were anesthe-
tized, 20 
 
 
 
l PBS (mock infection) or 20 
 
 
 
l of bacterial suspension
was delivered by pipette to the left external nares. The mouse was
held upright for 30–60 s after inoculation to assure aspiration. In-
oculation groups were staggered by 1 h to enable processing of all
animals at 
 
 
 
24 h after infection. 
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Physical Examination.
 
Mice were examined before euthanasia
for clinical signs of disease and were scored on a scale of 1 (worst)
to 5 (best) for scruffiness (1 
 
  
 
not groomed; 5 
 
  
 
clean fur), mo-
bility (1 
 
  
 
sitting upright and won’t move even when prodded;
5 
 
  
 
normal, active and eating), ocular character (1 
 
  
 
both eyes
closed, 5 
 
  
 
normal, both eyes open and bright), breath rate (1 
 
 
 
slow and labored; 5 
 
  
 
normal rapid, shallow breaths), and ap-
pearance of lung after removal (1 
 
  
 
both lobes red and hemor-
rhagic, 5 
 
  
 
pink and healthy). The total health rating is the mean
of the scores for the five criteria.
 
Euthanasia and Collection of Tissues.
 
At 24 h after infection,
mice were killed by CO
 
2
 
 asphyxiation and then exsanguinated by
cardiac puncture. The lungs and heart were removed with the
trachea intact. One lobe of the lung was clamped at the bronchial
bifurcation and the caudate lobe was removed. The remaining
lobe was injected with 4% paraformaldehyde in PBS through a
needle inserted into the trachea.
Bacterial Colonization and Quantification of TNF , IL-6, and
MIP-2. The excised caudate lobe of lung was weighed and then
homogenized in 5 ml Luria broth using an electric tissue tearor.
The homogenate was serially diluted and plated for V. cholerae
CFU counts. 1 ml of the undiluted homogenate was frozen on
dry ice and stored at –80 C. Blood collected by cardiac puncture
was set at room temperature for 2 h to allow blood to clot. The
serum was separated by centrifugation at 4,000 g, removed from
clot, and stored at –20 C. The concentrations of TNF  in the
undiluted lung homogenate and the serum titer of IL-6 and MIP-2
were determined by ELISA (R&D Systems).
Histopathology. Lungs preserved in paraformaldehyde were
embedded, sliced, mounted, and stained with hematoxylin and
eosin (H/E) at the Histology Core Facility of Beth Israel Dea-
conness Hospital (Boston, MA). Slides were scored by a veteri-
nary pathologist on a scale of 0 (no lesion) to 4 (severe) for degree
of pneumonia, degree of histopathology to the large airways and
alveoli, presence or absence of PMNs, macrophages, and type II
pneumocytes, and degree of perivascular edema. The composite
score is the sum of values for the seven criteria (maximum 28).
Data Analysis. Mice that died before 24 h of infection were
eliminated from further analysis. Statistical analyses were per-
formed using the Microsoft Excel Data Analysis Package t test as-
suming unequal variances. P values   0.05 were determined to
be statistically significant.
Results
Analysis of P4 (ctxAB::km) in a Mouse Model. As an ini-
tial test of the murine pulmonary cholera model, five mice
were inoculated intranasally with a sublethal dosage of V.
cholerae El Tor O1 strain P4, a derivative of the clinical iso-
late P27459 with a kanamycin-cassette replacing ctxA and
ctxB to eliminate production of CT (35). Three mice were
given 20  l PBS as a sham infection control. After 24 h,
the mice were killed and evaluated (Table I and Fig. 1).
The V. cholerae P4-inoculated mice exhibited decreased
activity, ocular discharge, malaise, heavy and labored
breathing, and ungroomed hair coat resulting in a low
overall health score. The lungs were mottled and dark red
and V. cholerae was culturable from the lung tissue. TNF 
was released to the local tissue and serum concentrations of
IL-6 and MIP-2 were elevated. Histologic examination of
the lungs revealed moderate diffuse or multifocal bronchi-
olar and alveolar pneumonia (Fig. 1). The predominant in-
flammatory cells present were PMNs with some activated
alveolar macrophages. In addition to the bronchiolar pneu-
monia, the lungs showed evidence of alveolar hemorrhage,
septal necrosis, accumulation of fibrous proteinaceous ma-
terial suspected to be eosinophilic fibrin, and moderate to
severe perivascular edema. Examination of the bronchiolar
epithelial lining demonstrated sloughing indicative of in-
jury and death of the epithelial barrier of the large airways.
The cytoplasm:nuclear ratio of these cells was altered sug-
gesting action of cytotoxins on these cells.
These observations are contrasted to those of the sham-
treated mice, which were physically active with normal
health scores. The levels of TNF , IL-6, and MIP-2 were
below detection limits (Table I). The pulmonary histology
did show some debris and slight focal hemorrhage, most
likely due to aspiration of PBS under anesthesia (Fig. 1).
These data demonstrate that V. cholerae can colonize the
lungs of adult immunocompetent mice and cause histologic
changes to the epithelial surfaces. The infection is inflam-
matory in nature as evidence by the influx of PMNs and
stimulation of proinflammatory molecules.
Comparison of Strains Deleted in Accessory Toxin Genes.
In a second series of experiments, the affect of accessory
toxins to the development of inflammation was assessed
compared with the ctxAB mutant strain P4 and sham-inoc-
ulated controls (Table II and Fig. 2).
Four mice were inoculated with KFV105, a derivative
of P4 bearing an in-frame deletion that removes 7.8 kb of
the rtxA gene and eliminates the RTX toxin-associated
cell rounding activity. By comparison to P4, infection of
mice with KFV105 resulted in a significantly improved
clinical score and decreased serum titers of IL-6 and MIP-2.
Table I. Initial Demonstration of Colonization and Stimulation of 
Proinflammatory Cytokines and Chemokines after Intranasal Infection 
of Mice with Nontoxigenic V. cholerae
P4 (ctxAB::km) Sham treated
Initial inoculum 2.3   107
CFU in 20  l
20  l 
PBS buffer
Mice surviving to 24 h 4/4 3/3
CFU recovered from lung 2,300–23,300
CFU/100 mg
0
Health rating 1.9   0.5a 5.0   0.0
Severity of pneumonia 13.5   4.4a 2.0   3.5
TNF  (pg/100 mg lung) 1,000   520
(range 570–1,800)a
 25
IL-6 (pg/ml serum) 3,400   2,700
(range 830–6,600)a
 37
MIP-2 (pg/ml serum) 2,100   2,600
(range 230–5,032)a
 120
aSignificantly different from sham-treated mice at P   0.05.1458 Proinflammatory Response to Vibrio cholerae Accessory Toxins
The CFU of KFV105 recovered from the lung was slightly
lower than for P4 suggesting a minor defect in coloniza-
tion or more rapid clearance by the immune system; how-
ever, differences in the CFU recovered were not statisti-
cally significant (P   0.22). The pathology of the lung
showed a moderate, multi-focal pneumonia, rather than
the severe, diffuse pneumonia observed for the P4-infected
mice. However, the overall severity score increased
slightly due to more evidence of perivascular edema and
recruitment of macrophages and type II pneumocytes.
Thus, loss of the RTX toxin rendered V. cholerae less
pathogenic, but not avirulent or noninflammatory, in this
mouse model.
Four mice were inoculated with a derivative of P4 bear-
ing an internal deletion in the gene for HAP. Among all
the deletion mutants tested, this is the only group in which
all four mice failed to survive to 24 h. The remaining two
mice were in poor health with very high titers of IL-6 and
MIP-2 and an overall severity score that exceeded that ob-
served for P4. In particular, injury to cells lining the large
airway is more severe than noted for P4-infected mice.
These data suggest that loss of this protease may have al-
Figure 1. V. cholerae induced pneumonia in BALB/c
mice. H/E staining of lung sections from mice inocu-
lated with P4 (top) or with control buffer (bottom). Fig-
ures at right are at 10  magnification of boxed section at
the left. Notable features are marked including fibrin (F),
hemorrhage (H), and epithelial cell sloughing (S).
Table II. Contribution of Accessory Toxins to Stimulation of Proinflammatory Molecules and Pathogenesis
Sham
treated
P4
(ctxAB::km)
KFV105
(P4 rtxA)
KFV70
(P4 hapA)
KFV103
(P4 hlyA)
KFV101
(P4 hapA hlyA rtxA)
Initial inoculum (in 20  l) PBS buffer 4.7   107 3.8   107 3.8   107 4.2   107 4.0   107
Mice surviving to 24 h 3/3 4/7 4/4 2/4 4/4 4/4
CFU recovered/100 mg lung
(range   103)
0 7.9–37 2.7–110 9.2–71 4.5–5,560 1.5–220
Health rating (scale 1 to 5) 4.7   0.5a 1.5   0.4 2.9   0.6a 1.6   0.3 1.8   0.4 4.0   0.4a, b
Severity of pneumonia
(scale 0 to 28)
2.0   1.7a 13.0   2.0 13.7   2.5 16.0   0.0 15.0   3.2 16.8   4.0
TNF  (pg/100 mg lung)  25 1,100   600 940   50 760   210 1,100   820 930   190
IL-6 (pg/ml serum)  37 7,000   4,500 730   200a 4,500   4,200 2,600c 250   160a, b
MIP-2 (pg/ml serum)  120 range
2,400–64,000
range
230–1,200a
range
63,00–70,00
range
2,300–25,000
 120a, b
aValue is significantly different from value for P4 (P   0.05).
bValue is significantly different from value for KFV105 (P   0.05).
cIL-6 assayed for only one mouse as other samples were insufficient after MIP-2 test.1459 Fullner et al.
tered the course of infection to be more lethal, although
none of the measured values were significantly different
from the P4 group, in part due to lack of samples.
Four mice were inoculated with a derivative of P4 bear-
ing an internal deletion in the gene for hemolysin. Mice in
this group were heavily colonized and in poor health at 24 h.
Sampling of blood and testing of serum from this group
was difficult as the blood was often thickened. Evaluation
of the lung pathology revealed a dense pneumonia charac-
terized by consolidation, pleuritis, and sloughing in the ma-
jor airways indicative of a more severe pneumonia as com-
pared with the P4 control group.
These results demonstrated that the RTX toxin is the
only one of the three toxins that significantly contributed
to the enhancement of inflammation as demonstrated by
improved pathology and decreased titers of proinflamma-
tory molecules MIP-2 and IL-6 when the rtxA gene is de-
leted. The apparent worsening of pathology due to dele-
tion of hapA or hlyA may reflect antiinflammatory action
by these toxins or an alteration in the delivery of other tox-
ins to specific tissues and thus a loss of the coordinated
modulation of the immune system.
A Multi-toxin Mutant Has Significantly Decreased Viru-
lence. The additive effects of these toxins to disease was
demonstrated by an improved health score and decreased
serum titers of IL-6 and MIP-2 when a multi-toxin mutant
strain KFV101, with deletions in ctxAB, rtxA, hapA, and
hlyA, was assessed. These data are statistically significant
when compared with P4 and to other mutants deleted of
any single toxin, most notably the rtxA deletion KFV105
(Table II and Fig. 2).
The lungs of these mice were relatively clear compared
with other samples although this is not reflected in the se-
verity score. A breakdown of the severity score revealed
that the increase in score is due primarily to high values for
PMNs in alveolar spaces and type II pneumocytes suggest-
ing that the immune systems in these mice are responding
to the infection before the onset of dense pneumonia.
The overall improvement in the pathology suggested
that mice infected with the multi-toxin mutant might suc-
cessfully clear the infection and survive the bacterial chal-
lenge. To test this, 10 mice were inoculated with either P4
or KFV101 and the mice were monitored for seven days.
80% of mice in the P4 group died within 3 d, while all 10
mice inoculated with KFV101 survived 7 d (Fig. 3). The
KFV101-infected mice originally showed signs of infection
but gradually returned to normal activity after 1 to 2 d.
Most strikingly, the two survivors challenged with P4
showed weight loss to an average of 12.1 g (or a loss of
 33% body weight) while the KFV101 survivors main-
tained a weight of 18–20 g. These data show that mice can
survive a challenge of KFV101 that is lethal when the ex-
tracellular toxins are produced.
Dissemination of Disease. The magnitude of hemorrhage
and the diffuse nature of the pneumonia in P4-infected
mice suggest that bacteria may have transversed the epithe-
lial barriers and invaded adjacent tissues. To test this possi-
bility, a total of nine mice each were infected with either
P4 or KFV101 in two different experiments, one termi-
nated at 24 h and the other at 18 h. Of six survivors in the
P4 group, five had disseminated infections as indicated by
recovery of kanamycin and streptomycin resistant V. chol-
erae from the liver and spleen. By contrast, KFV101 never
led to a disseminated infection in the first two experiments.
An additional seven mice were inoculated with a fivefold
higher dose of KFV101 and dissemination was charted. Of
Figure 2. Loss of specific cy-
totoxins affects acute pathology
of pulmonary disease. Lung sec-
tions from mice intranasally in-
oculated with P4 and four
isogenic mutants were selected
for areas demonstrating epithelial
lined bronchioles and alveolar air
spaces. Note increase numbers of
inflammatory cells in the alveoli
of the exposed tissue of KFV70
( hapA) KFV103 ( hlyA), when
compared with the KFV105
( rtxA), KFV101 ( hapA,  hlyA,
 rtxA), and sham-treated sam-
ples (H/E, 100 ).1460 Proinflammatory Response to Vibrio cholerae Accessory Toxins
five mice that were colonized in the lung at 24 h, four de-
veloped disseminated infections. Thus, the accessory toxins
may contribute to septicemia at lower dosages but they are
not absolutely essential for dissemination.
Discussion
Innate immune responses to V. cholerae infection have
not been intensely studied in part due to the absence of
a murine model for pathogenesis. The suckling mouse
model has proven useful for the study of bacterial coloniza-
tion and regulation of virulence factors (37). However,
these 5–6-d-old mice do not have immune systems suffi-
ciently developed for study of immunomodulation. Adult
germ-free mouse models have been useful for evaluation of
immunogenic potential of oral V. cholerae vaccine strains even
though colonization may not occur (38), yet neither of
these models is applicable for study of acute inflammatory
responses. In this study, we report the use of a novel mouse
model conceptually adapted from the studies of S. flexneri
(30–32) and technically based on previous studies with
Pseudomonas aeruginosa (39). We have demonstrated that V.
cholerae can infect the lung of BALB/c mice leading to the
development of inflammation.
The identity of the “reactogenicity factor” of V. cholerae
vaccine strains has been elusive. Indeed, determination of
this factor was identified by the National Institute of
Health in 1996 as one of the top priorities for enteric dis-
ease research (40) and improvement of available vaccines
has been recommended by the World Health Organization
(41). Using this in vivo model, we suggest that the “reac-
togenicity” factor is likely a trio of factors consisting of
HAP, hemolysin, and the RTX toxin. Genetic manipula-
tion resulting in the loss of these cytotoxins led to a change
of the course of the disease, particularly in the pathology.
Most prominently, these studies revealed that the RTX
toxin is a key factor in the stimulation of the proinflamma-
tory mediators IL-6 and MIP-2. Although compound de-
letion of rtxA and ctxAB did not generate an avirulent
strain, the decrease in serum levels of IL-6 and MIP-2 and
improvement in the clinical signs of disease compared with
the single ctxAB deletion strain are the first observations
linking the RTX toxin to pathogenesis in vivo. By con-
trast, histopathologic evidence indicates that V. cholerae
strains deleted of hlyA or hapA in addition to deletion of
ctxAB are potentially more virulent than the parent strain.
Conversely, absence of these toxins in addition to the
RTX toxin led to improved pathology and decreased se-
rum titers of IL-6 and MIP-2 suggesting these toxin some-
how work in concert.
These results predict that deletion of the genes for a sin-
gle accessory toxin would not subvert cholera vaccine reac-
togenicity. This prediction is supported by results from hu-
man vaccine trials. Double mutants lacking ctx genes in
combination with hlyA (42), hapA (43), or rtxA (44) have
been tested in phase I vaccine trials and each double mutant
retained some virulence. The data presented here on
KFV101, deleted of ctxAB, hlyA, hapA, and rtxA, would
suggest that the use of a multi-toxin knockout vaccine
strain might prevent the clinical side effects of the current
candidate vaccine strains.
It is notable that the strain P4 is frequently used as a
source of kanamycin-resistant CTX  phage particles indi-
cating it produces the CTX  phage assembly proteins Zot
and Ace, which have also been proposed as accessory toxins
that could contribute to reactogenicity. In a separate exper-
iment, Bang-1, a CTX  core deletion strain derived from
P27459 (45), was found to have no significant difference in
the course of disease compared with P4 suggesting that loss
of the proteins Zot and Ace does not reduce or increase
virulence of V. cholerae in this model.
The combination of in vitro and in vivo results would
suggest that the enhancement of the proinflammatory re-
sponse by these accessory toxins is due to increased tissue
damage when the toxin are expressed. However, further
experimentation is required to characterize the mouse pul-
monary model of cholera and to more thoroughly investi-
gate the roles of the RTX toxin, HAP, and hemolysin in
pathogenesis and in the induction of the proinflammatory
immune response. The advantage of this model is that it is
suitable for use in studies of cholera infection in a broad
range of commercially available knockout mice including
mice deficient in production of IL-6, MIP-2, IL-1 , and
various Toll-like and cytokine receptors implicated in the
innate immune response to bacterial infections. In addition,
the observations reported here suggest that this model
could be applied as an initial screen for the prediction of
proinflammatory potential of putative vaccine strains before
initiation of more succinct studies in the well established,
Figure 3. Mice challenge with multi-toxin deleted strain KFV101 sur-
vive. 10 mice were inoculated with either 2   107 P4 (dashed line) or
KFV101 (solid line) and mice were followed for 7 d. The time of death
was noted for each mouse as indicated in graph. Surviving mice were
killed after 7 d.1461 Fullner et al.
but more expensive, rabbit model for intestinal cholera dis-
ease or before launching phase I human clinical trials.
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